Background
==========

Hepatocellular carcinoma (HCC) is the sixth most common malignant tumor and the second leading cause of cancer-related deaths in the world.[@b1-ott-11-3225] The onset of HCC is relatively insidious; in most cases, HCC is diagnosed at advanced stages and is difficult to treat. Presently, surgical resection-based comprehensive treatment is the main treatment for HCC, but with less success rate and high rates of recurrence and metastasis.[@b2-ott-11-3225] Therefore, improving the early diagnosis is particularly important in the prevention and treatment of HCC. Determining the association between KIF1B (rs17401966) polymorphism and HCC risk provides a promising approach to achieve this goal.

KIF1B is a member of the kinesin superfamily and belongs to N-kinesin, encoding two alternatively spliced isoforms, KIF1Bα and KIF1Bβ. Both the isoforms have the same 660 amino acid residues in the N terminal domain; the main difference between them is the end of the C binding domain, conferring different axonal cargo specificity.[@b3-ott-11-3225] KIF1B is located in chromosome region 1p36.22 and is an important molecule for intracellular vesicle trafficking and organelle transporting.[@b4-ott-11-3225],[@b5-ott-11-3225] In addition to transport function, KIF1B also plays an important role in tumor suppression by promoting apoptosis.[@b6-ott-11-3225] Studies have shown that deficiency of 1p36 region is very common in the individuals with early-onset HCC, but the phenomenon is not observed in individuals with chronic liver disease. It can be speculated that the abnormal chromosomal regions may be associated with the risk of HCC.[@b7-ott-11-3225]

Through genome-wide association study (GWAS), Zhang et al[@b8-ott-11-3225] found a significant association between KIF1B rs17401966 polymorphism and HCC, showing that the polymorphism of the site has a protective effect on HCC. However, a consistent conclusion on the correlation between the gene polymorphism and HCC was not reached, which may be caused by differences in race or ethnicity, as well as the difference in sample size.[@b8-ott-11-3225]--[@b18-ott-11-3225] Therefore, we carried out a meta-analysis of the whole included case--control studies to make a more accurate estimate of the association.

Methods
=======

Literature searching strategy
-----------------------------

A comprehensive literature searching for all relevant studies published before March 25, 2018 was conducted in PubMed, Web of Science and the Cochrane Library, using the following keywords: KIF1B/Kinesin family member 1B/rs17401966 and locus/mutation/variant\*/genotype/polymorphism\*/SNP and (\[liver/hepatic/hepatocellular/hepatocellular and carcinom\*/cancer/neoplasm\*/malign\*/tumor\] or HCC or hepatoma\*) and the combinations. The relevant bibliographies of identified studies were examined for additional articles. Abstracts and citations were screened by two researchers independently, and any disagreements were resolved by discussing with a third reviewer. The full text of all the eligible articles was reviewed during a second screening. There were no language limitations during the retrieval procedure.

Selection and exclusion criteria
--------------------------------

All eligible studies included in this meta-analysis met the following inclusion criteria: 1) independent case--control studies performed on humans; 2) evaluated the association between KIF1B (rs17401966) polymorphism and HCC risk; 3) genotype frequencies in case and control groups were available for risk estimate; 4) the diagnosis of the cases was based on pathology; 5) control subjects had no cancer and history of radiotherapy or chemotherapy; and 6) genotype frequencies of the subjects in control groups were in accordance with Hardy--Weinberg equilibrium (HWE). We excluded abstracts, case reports, letters, comments, editorials, reviews, meta-analyses and studies lacking sufficient data. Simultaneously, if the researches were duplicated or shared in more than one study, the most recent publications were included.

Data extraction and synthesis
-----------------------------

We used endnote bibliographic software (EndNote X6) to construct an electronic library of citations identified in the literature search. Duplicates were found automatically by endnote and deleted manually. All the extracted data were checked and evaluated twice according to the inclusion criteria listed above by two independent investigators. The following data were extracted from each study: first author, year of publication, country, ethnicity, genotyping method, number of cases and controls, genotype distribution of cases and controls and *P*-value of HWE in controls. Meanwhile, multicenter studies were divided into several separate studies according to the origin. A third reviewer participated if some disagreements emerged, and a final decision was not made until a consensus was reached.

Quality assessment
------------------

The methodological quality assessment was performed based on the modified scoring system used for studies on genetic epidemiological issues.[@b19-ott-11-3225] Points were awarded on the basis of representativeness of cases, source of controls, HWE in controls, genotyping examination and association assessment. Total score ranged from 0 (lowest quality) to 8 (highest quality). A study with a score of ≥6 was classified to be of high quality.

Statistical analysis
--------------------

All statistical analyses were carried out using STATA version 11.0 (StataCorp LP, College Station, TX, USA) and Review Manager version 5.2.0 (The Cochrane Collaboration, 2012). Chi-square test was applied to calculate *P*-value of HWE in controls, and *P*\>0.05 was considered to be consistent with HWE.[@b20-ott-11-3225] The association of KIF1B (rs17401966) polymorphism and HCC susceptibility was estimated by pooled ORs with 95% CIs under five different genetic models including allele model, dominant model, recessive model, homozygous genetic model and heterozygous genetic model. *Z* test was used to assess the significance of the ORs. Both *Q*-statistic test and *I*^2^ test were applied to assess the between-study heterogeneity in this meta-analysis. If there was significant heterogeneity among included studies (*P*-value of *Q*-statistic was \<0.1, or *I*^2^ value was \>75%), ORs with corresponding 95% CIs were calculated using the random effects model; otherwise, the fixed effects model was selected.[@b20-ott-11-3225],[@b21-ott-11-3225] The subgroup analysis was conducted based on ethnicity and age (\>50 years or ≤50 years). For studies with Chinese population, we also conducted subgroup analysis by region and environment. Sensitivity analyses were performed to assess the stability of the results. Each study involved in this meta-analysis was deleted each time to reflect the influence of the individual data exerted on the pooled OR. We used Begg's funnel plot and Egger's test (*P*\<0.05 was considered significant) to evaluate the publication bias.[@b22-ott-11-3225],[@b23-ott-11-3225] All statistical tests were two-sided, and *P*\<0.05 indicated statistical significance.

Results
=======

Characteristics of the included studies
---------------------------------------

The selection process of eligible studies is presented in [Figure 1](#f1-ott-11-3225){ref-type="fig"}. A total of 59 relevant articles were preliminarily identified based on our selection strategy. We also identified one article through other sources.[@b18-ott-11-3225] Thirty-five articles remained after eliminating duplicated literature. Subsequently, 16 obviously irrelevant articles were excluded unquestionably after reviewing their titles and abstracts. Based on the inclusion and exclusion criteria, eight articles were excluded after reviewing the full text. Finally, 11 studies were eventually included in this meta-analysis.[@b8-ott-11-3225]--[@b18-ott-11-3225] The 11 case--control studies were published between 2010 and 2016. Among them, Zhang et al's research consisting of five independent studies was divided into five studies.[@b8-ott-11-3225] Similarly, Li et al's and Sawai et al's articles were divided into two and four studies, respectively.[@b13-ott-11-3225],[@b15-ott-11-3225] Thus, a total of 19 studies from 11 articles with 8,741 cases and 10,812 controls were included in this meta-analysis. A summary of the characteristics of the 19 studies, including first author, year of publication, country, ethnicity, genotyping method, age of cases, number of cases and controls, *P*-value of HWE and quality score, is shown in [Table 1](#t1-ott-11-3225){ref-type="table"}. Based on quality assessment, all studies were considered to be of high quality (quality scores of these studies were 6--8).

Meta-analysis results
---------------------

The genotype distribution and allele frequencies of KIF1B (rs17401966) polymorphism in cases and controls are listed in [Table 2](#t2-ott-11-3225){ref-type="table"}. The main results of our study are shown in [Tables 3](#t3-ott-11-3225){ref-type="table"} and [4](#t4-ott-11-3225){ref-type="table"}.

As shown in [Table 3](#t3-ott-11-3225){ref-type="table"} and [Figure 2](#f2-ott-11-3225){ref-type="fig"}, the pooled results indicated that the association between KIF1B (rs17401966) polymorphism and the decreased occurrence of HCC was significant in overall population in three genetic models: allele model (OR=0.87, 95% CI=0.78--0.97, *P*=0.01), dominant model (OR=0.84, 95% CI=0.74--0.94, *P*=0.003) and heterozygote comparison (OR=0.84, 95% CI=0.76--0.93, *P*=0.0009). The subgroup analysis stratified by ethnicity showed the same association in Chinese population (allele model: OR=0.84, 95% CI=0.74--0.96, *P*=0.009; dominant model: OR=0.81, 95% CI=0.71--0.93, *P*=0.003; homozygous genetic model: OR=0.74, 95% CI=0.56--0.98, *P*=0.03; heterozygote comparison: OR=0.83, 95% CI=0.74--0.93, *P*=0.001) ([Figure 3](#f3-ott-11-3225){ref-type="fig"}), while no genetic model showed significant association in non-Chinese. When stratified by age, we found that both old (allele model: OR=0.86, 95% CI=0.76--0.98, *P*=0.02; dominant model: OR=0.83, 95% CI=0.73--0.95, *P*=0.006; heterozygote comparison: OR=0.85, 95% CI=0.76--0.94, *P*=0.002) and young patients (allele model: OR=0.75, 95% CI=0.59--0.97, *P*=0.03; dominant model: OR=0.73, 95% CI=0.56--0.96, *P*=0.03; recessive model: OR=0.64, 95% CI=0.41--0.99, *P*=0.04; homozygous genetic model: OR=0.57, 95% CI=0.34--0.95, *P*=0.03; heterozygote comparison: OR=0.77, 95% CI=0.60--0.97, *P*=0.03) showed a significant association between KIF1B (rs17401966) polymorphism and decreased HCC risk ([Figure 4](#f4-ott-11-3225){ref-type="fig"}).

For studies with Chinese population, we also conducted subgroup analysis by region and environment. As shown in [Table 4](#t4-ott-11-3225){ref-type="table"}, when stratified by region (northern China, central China, southern China), we detected an association of the KIF1B (rs17401966) polymorphism with decreased HCC risk in Chinese in southern China based on heterozygote comparison (OR=0.78, 95% CI=0.63--0.98, *P*=0.03) ([Figure 5](#f5-ott-11-3225){ref-type="fig"}). When stratified by environment (inland areas, coastal areas), we observed an association between decreased HCC risk and KIF1B (rs17401966) polymorphism in Chinese in inland areas (allele model: OR=0.76, 95% CI=0.61--0.96, *P*=0.02; dominant model: OR=0.73, 95% CI=0.58--0.94, *P*=0.01; homozygous genetic model: OR=0.60, 95% CI=0.36--0.98, *P*=0.04; heterozygote comparison: OR=0.77, 95% CI=0.63--0.94, *P*=0.01) ([Figure 6](#f6-ott-11-3225){ref-type="fig"}); however, no statistically significant association was observed in those in coastal areas.

Sensitivity analyses
--------------------

As shown in [Table 1](#t1-ott-11-3225){ref-type="table"}, all the studies were in line with the balance of HWE in control groups. To evaluate the stability of our results, we performed sensitivity analysis to assess the effect of each individual study on the pooled ORs. After excluding each study sequentially, the corresponding ORs were not substantially changed, suggesting that the results of our meta-analysis were stable and reliable.

Heterogeneity analysis
----------------------

Heterogeneity among studies was assessed by *Q*-statistic. Random effects models were applied if *P*-value of heterogeneity tests was ≤0.1 or *I*^2^ was ≥75% (*P*≤0.1 or *I*^2^≥75%), otherwise, fixed effects models were selected ([Tables 3](#t3-ott-11-3225){ref-type="table"} and [4](#t4-ott-11-3225){ref-type="table"}).

Publication bias
----------------

Begg's test, Egger's test and funnel plot were all used to evaluate the publication bias of the included studies. No significant publication bias was found in Begg's and Egger's test (*P*\>0.05). Funnel plot also indicated that publication bias did not exist with no obvious asymmetry that could be observed ([Figure 7](#f7-ott-11-3225){ref-type="fig"}).

Discussion
==========

GWASs have been shown to be unbiased and effective in exploring disease phenotype-associated single-nucleotide polymorphism (SNP). Currently, a large number of GWASs have been reported, most of which are about cancer.[@b24-ott-11-3225] Epidemiological and experimental studies have shown that HCC is a complex disease that occurs due to multiple factors, including viral, environmental and genetic factors. With the same environmental background, a small number of people suffer from HCC, whereas others do not, which also shows the importance of genotype. GWASs have found a number of HCC-associated SNPs, such as K1F1B, MICA, HLA-DQA/DQB, SL47W and so on.[@b12-ott-11-3225],[@b13-ott-11-3225],[@b25-ott-11-3225],[@b26-ott-11-3225] The existence of genetic etiology of HCC is further confirmed. Identification of HCC susceptibility genes and gene-related molecular mechanisms will provide a theoretical basis for the prevention and clinical diagnosis of HCC and treatment of population at high HCC risk. It is expected to achieve early prevention and individualized treatment of HCC and to improve the therapeutic effect of HCC.

Through GWAS, Zhang et al[@b8-ott-11-3225] found a significant association between KIF1B rs17401966 polymorphism and HCC, showing that the polymorphism of the site has a protective effect on HCC. However, a consistent conclusion on the correlation between the gene polymorphism and HCC was not reached.[@b8-ott-11-3225]--[@b18-ott-11-3225] Hence, we performed this meta-analysis aiming to illuminate the association between KIF1B (rs17401966) polymorphism and HCC. The pooled results of our study indicated that the association was significant. Subgroup analysis stratified by ethnicity showed the same association in Chinese population, but not in non-Chinese. All the above results were consistent with the results of the meta-analysis of Zhang et al[@b27-ott-11-3225] and Wang et al.[@b28-ott-11-3225] However, the number of included papers in their analysis was less than that in our study. When stratified by age, both old and young patients showed decreased HCC risk, which was consistent with the results of Zhang et al's[@b27-ott-11-3225] study. When stratified by region (northern China, central China, southern China), we detected an association between KIF1B (rs17401966) polymorphism and decreased HCC risk in Chinese in southern China. When stratified by environment (inland areas, coastal areas), we observed the same association in Chinese in Inland areas; however, no statistically significant association was observed in those in coastal areas. It was the first subgroup analysis on Chinese population stratified by region and environment.

Zhang et al[@b27-ott-11-3225] also performed subgroup analysis by gender and found that KIF1B rs17401966 polymorphism was significantly associated with HCC in men but not in women. However, the number of papers from which gender data were extracted for their study was only five, and the sample size of women was extremely small. Therefore, we should interpret the results of their study with caution. Zhang et al[@b27-ott-11-3225] also performed subgroup analysis based on sample sizes and quality scores and found that rs17401966 polymorphism was significantly associated with reduced HCC risk in studies with large sample size and of high quality; however, no significant associations were found in studies with small sample size and of low quality. However, we should realize that small sample sizes and low-quality scores were sources for this heterogeneity, so subgroup analyses stratified by sample sizes and quality scores may not be appropriate.

Nevertheless, some limitations of our meta-analysis should be addressed. First, we could not obtain all the raw data of the patients and hence could not conduct subgroup analysis by sex, hepatitis, liver function and other variables. We also failed to clarify gene--gene and gene--environment interactions in the occurrence and development of HCC. Second, only published studies were included in this meta-analysis; however, some unpublished papers may exist and conform to our inclusion criteria. Therefore, publication bias may have appeared, although no statistical evidence was found. Third, our research is only a comprehensive analysis of existing data. We did not verify the association through basic experiments. Moreover, the included papers were mostly based on Chinese population; only four papers were about non-Chinese. Therefore, data from large-scale multicenter studies based on non-Chinese population are still needed to confirm the association between KIF1B (rs17401966) polymorphism and HCC.

Conclusion
==========

Our meta-analysis indicates that KIF1B (rs17401966) polymorphism could decrease HCC risk in Chinese and in overall population, but not in non-Chinese. This association remained significant in Chinese in southern China and inland areas, but not in those in northern or central China and in coastal areas. Further large-scale multicenter studies are warranted to confirm our findings.
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![Forest plots of the KIF1B (rs17401966) polymorphism and hepatocellular carcinoma risk in subgroup stratified by age (heterozygous genetic model, AG vs GG).\
**Abbreviations:** *df*, degrees of freedom; M--H, Mantel--Haenszel; NR, not reported.](ott-11-3225Fig4){#f4-ott-11-3225}
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**Abbreviations:** *df*, degrees of freedom; M--H, Mantel--Haenszel.](ott-11-3225Fig5){#f5-ott-11-3225}
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**Abbreviations:** *df*, degrees of freedom; M--H, Mantel--Haenszel.](ott-11-3225Fig6){#f6-ott-11-3225}

![Funnel plot assessing evidence of publication bias from 19 studies (heterozygous genetic model, AG vs GG).\
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###### 

Characteristics of the studies included in the meta-analysis

  First author                       Year   Country    Ethnicity             Genotyping method     Age     Number (case/control)   HWE        Quality score
  ---------------------------------- ------ ---------- --------------------- --------------------- ------- ----------------------- ---------- ---------------
  Chen et al[@b9-ott-11-3225]        2013   China      Chinese (Beijing)     TaqMan                53.9    503/772                 0.646837   6
  Chen et al[@b10-ott-11-3225]       2016   China      Chinese (Guangdong)   TaqMan                55.84   306/306                 0.05846    7
  Hu et al[@b11-ott-11-3225]         2012   China      Chinese (Jiangsu)     TaqMan                52.9    1,293/2,671             0.05058    6
  Jiang et al[@b12-ott-11-3225]      2013   China      Chinese (Jiangsu)     TaqMan                51.6    1,161/1,353             0.982272   8
  Li et al[@b13-ott-11-3225]         2012   China      Chinese (Guangdong)   iPLEX or TaqMan       49.3    1,058/981               0.975939   6
  Li et al[@b13-ott-11-3225]         2012   China      Chinese (Shanghai)    iPLEX or TaqMan       49.3    480/484                 0.962279   6
  Pan et al[@b14-ott-11-3225]        2015   China      Chinese (Fujian)      MassARRAY Typer 4.0   61.7    376/403                 0.132385   8
  Sawai et al[@b15-ott-11-3225]      2012   Japan      Japanese              PCR                   62      179/769                 0.31108    7
  Sawai et al[@b15-ott-11-3225]      2012   Japan      Japanese              TaqMan                61.3    142/251                 0.970885   7
  Sawai et al[@b15-ott-11-3225]      2012   Japan      Korean                TaqMan                52.2    164/144                 0.325085   7
  Sawai et al[@b15-ott-11-3225]      2012   Japan      Chinese (Hong Kong)   TaqMan                58      93/187                  0.466716   7
  Sopipong et al[@b16-ott-11-3225]   2013   Thailand   Thais                 PCR                   59.8    202/196                 0.764716   6
  Su et al[@b17-ott-11-3225]         2014   China      Chinese (Fujian)      MALDI-TOF-MS          NR      160/160                 0.71155    6
  Su[@b18-ott-11-3225]               2015   China      Chinese (Fujian)      MALDI-TOF             NR      314/346                 0.405123   6
  Zhang et al[@b8-ott-11-3225]       2010   China      Chinese (Guangxi)     Affymetrix            45.8    348/359                 0.98702    7
  Zhang et al[@b8-ott-11-3225]       2010   China      Chinese (Beijing)     Affymetrix            55.9    276/266                 0.805902   7
  Zhang et al[@b8-ott-11-3225]       2010   China      Chinese (Jiangsu)     Affymetrix            52.7    507/215                 0.393367   7
  Zhang et al[@b8-ott-11-3225]       2010   China      Chinese (Guangdong)   Affymetrix            49.3    751/509                 0.906845   7
  Zhang et al[@b8-ott-11-3225]       2010   China      Chinese (Shanghai)    Affymetrix            50.6    428/440                 0.777482   7

**Abbreviations:** HWE, Hardy--Weinberg equilibrium; NR, not reported; PCR, polymerase chain reaction; MALDI-TOF-MS, matrix-associated laser desorption ionization-time of flight-mass spectrometry.

###### 

KIF1B (rs17401966) polymorphisms genotype distribution and allele frequency in cases and controls

  First author                       Year   Genotype (N)   Allele frequency (N)                                                                   
  ---------------------------------- ------ -------------- ---------------------- ----- ----- ------- ----- ------- ------- ----- ------- ------- -------
  Chen et al[@b9-ott-11-3225]        2013   503            63                     194   246   772     65    309     398     320   686     439     1,105
  Chen et al[@b10-ott-11-3225]       2016   306            21                     126   159   306     18    138     150     168   444     174     438
  Hu et al[@b11-ott-11-3225]         2012   1,293          107                    480   706   2,671   231   1,038   1,402   694   1,892   1,500   3,842
  Jiang et al[@b12-ott-11-3225]      2013   1,161          84                     458   619   1,353   106   546     701     626   1,696   758     1,948
  Li et al[@b13-ott-11-3225]         2012   1,058          77                     417   564   981     77    395     509     571   1,545   549     1,413
  Li et al[@b13-ott-11-3225]         2012   480            35                     189   256   484     41    199     244     259   701     281     687
  Pan et al[@b14-ott-11-3225]        2015   376            34                     138   204   403     53    167     183     206   546     273     533
  Sawai et al[@b15-ott-11-3225]      2012   179            13                     61    105   769     45    261     463     87    271     351     1,187
  Sawai et al[@b15-ott-11-3225]      2012   142            5                      46    91    251     14    91      146     56    228     119     383
  Sawai et al[@b15-ott-11-3225]      2012   164            17                     59    88    144     15    55      74      93    235     85      203
  Sawai et al[@b15-ott-11-3225]      2012   93             10                     39    44    187     13    80      94      59    127     106     268
  Sopipong et al[@b16-ott-11-3225]   2013   202            21                     81    100   196     16    83      97      123   281     115     277
  Su et al[@b17-ott-11-3225]         2014   160            24                     60    76    160     16    66      78      108   212     98      222
  Su[@b18-ott-11-3225]               2015   314            32                     153   129   346     26    149     171     217   411     201     491
  Zhang et al[@b8-ott-11-3225]       2010   348            8                      100   240   359     26    141     192     116   580     193     525
  Zhang et al[@b8-ott-11-3225]       2010   276            5                      86    185   266     24    109     133     96    456     157     375
  Zhang et al[@b8-ott-11-3225]       2010   507            26                     181   300   215     21    101     93      233   781     143     287
  Zhang et al[@b8-ott-11-3225]       2010   751            26                     228   497   509     35    195     279     280   1,222   265     753
  Zhang et al[@b8-ott-11-3225]       2010   428            12                     141   275   440     32    169     239     165   691     233     647

###### 

Overall meta-analysis results with subgroup conducted by ethnicity and age

  Outcome or subgroup        Studies   Participants   Statistical method          Effect estimate     *P*-value   Heterogeneity   
  -------------------------- --------- -------------- --------------------------- ------------------- ----------- --------------- -----------
  Allele model                                                                                                                    
   Overall                   19        39,106         OR (M--H, random, 95% CI)   0.87 (0.78, 0.97)   0.01        80%             \<0.00001
   Chinese                   15        35,012         OR (M--H, random, 95% CI)   0.84 (0.74, 0.96)   0.009       84%             \<0.00001
   Non-Chinese               4         4,094          OR (M--H, fixed, 95% CI)    0.98 (0.84, 1.15)   0.84        0%              0.53
   \>50 years                13        27,206         OR (M--H, random, 95% CI)   0.86 (0.76, 0.98)   0.02        77%             \<0.00001
   ≤50 years                 4         9,940          OR (M--H, random, 95% CI)   0.75 (0.59, 0.97)   0.03        85%             0.0001
  Dominant model                                                                                                                  
   Overall                   19        19,553         OR (M--H, random, 95% CI)   0.84 (0.74, 0.94)   0.003       72%             \<0.00001
   Chinese                   15        17,506         OR (M--H, random, 95% CI)   0.81 (0.71, 0.93)   0.003       78%             \<0.00001
   Non-Chinese               4         2,047          OR (M--H, fixed, 95% CI)    0.95 (0.78, 1.16)   0.63        0%              0.71
   \>50 years                13        13,603         OR (M--H, random, 95% CI)   0.83 (0.73, 0.95)   0.006       66%             0.0004
   ≤50 years                 4         4,970          OR (M--H, random, 95% CI)   0.73 (0.56, 0.96)   0.03        82%             0.001
  Recessive model                                                                                                                 
   Overall                   19        19,553         OR (M--H, random, 95% CI)   0.85 (0.69, 1.04)   0.12        67%             \<0.0001
   Chinese                   15        17,506         OR (M--H, random, 95% CI)   0.80 (0.63, 1.02)   0.08        73%             \<0.00001
   Non-Chinese               4         2,047          OR (M--H, fixed, 95% CI)    1.09 (0.75, 1.57)   0.66        0%              0.64
   \>50 years                13        13,603         OR (M--H, random, 95% CI)   0.85 (0.66, 1.11)   0.23        67%             0.0003
   ≤50 years                 4         4,970          OR (M--H, random, 95% CI)   0.64 (0.41, 0.99)   0.04        68%             0.03
  Homozygous genetic model                                                                                                        
   Overall                   19        12,024         OR (M--H, random, 95% CI)   0.79 (0.62, 1.00)   0.05        74%             \<0.00001
   Chinese                   15        10,714         OR (M--H, random, 95% CI)   0.74 (0.56, 0.98)   0.03        79%             \<0.00001
   Non-Chinese               4         1,310          OR (M--H, fixed, 95% CI)    1.06 (0.72, 1.54)   0.77        0%              0.58
   \>50 years                13        8,366          OR (M--H, random, 95% CI)   0.79 (0.59, 1.06)   0.11        73%             \<0.0001
   ≤50 years                 4         3,106          OR (M--H, random, 95% CI)   0.57 (0.34, 0.95)   0.03        76%             0.006
  Heterozygote comparison                                                                                                         
   Overall                   19        18,059         OR (M--H, random, 95% CI)   0.84 (0.76, 0.93)   0.0009      56%             0.002
   Chinese                   15        16,158         OR (M--H, random, 95% CI)   0.83 (0.74, 0.93)   0.001       64%             0.0003
   Non-Chinese               4         1,901          OR (M--H, fixed, 95% CI)    0.93 (0.76, 1.15)   0.52        0%              0.87
   \>50 years                13        12,532         OR (M--H, random, 95% CI)   0.85 (0.76, 0.94)   0.002       39%             0.07
   ≤50 years                 4         4,645          OR (M--H, random, 95% CI)   0.77 (0.60, 0.97)   0.03        74%             0.01

**Abbreviation:** M--H, Mantel--Haenszel.

###### 

Subgroup meta-analysis results of Chinese conducted by region and environment

  Outcome or subgroup        Studies   Participants   Statistical method          Effect estimate     *P*-value   Heterogeneity   
  -------------------------- --------- -------------- --------------------------- ------------------- ----------- --------------- -----------
  Allele model                                                                                                                    
   Overall                   15        35,012         OR (M--H, random, 95% CI)   0.84 (0.74, 0.96)   0.009       84%             \<0.00001
   Northern China            2         3,634          OR (M--H, random, 95% CI)   0.77 (0.34, 1.78)   0.55        96%             \<0.00001
   Central China             8         21,582         OR (M--H, random, 95% CI)   0.88 (0.76, 1.01)   0.07        79%             \<0.0001
   Southern China            5         9,796          OR (M--H, random, 95% CI)   0.81 (0.63, 1.04)   0.1         84%             \<0.0001
   Inland areas              6         19,448         OR (M--H, random, 95% CI)   0.76 (0.61, 0.96)   0.02        90%             \<0.00001
   Coastal areas             9         15,564         OR (M--H, random, 95% CI)   0.90 (0.77, 1.05)   0.18        77%             \<0.0001
  Dominant model                                                                                                                  
   Overall                   15        17,506         OR (M--H, random, 95% CI)   0.81 (0.71, 0.93)   0.003       78%             \<0.00001
   Northern China            2         1,817          OR (M--H, random, 95% CI)   0.75 (0.34, 1.66)   0.48        93%             0.0001
   Central China             8         10,791         OR (M--H, random, 95% CI)   0.85 (0.72, 1.01)   0.06        74%             0.0003
   Southern China            5         4,898          OR (M--H, random, 95% CI)   0.77 (0.59, 1.01)   0.05        78%             0.001
   Inland areas              6         9,724          OR (M--H, random, 95% CI)   0.73 (0.58, 0.94)   0.01        86%             \<0.00001
   Coastal areas             9         7,782          OR (M--H, random, 95% CI)   0.87 (0.73, 1.03)   0.11        69%             0.001
  Recessive model                                                                                                                 
   Overall                   15        17,506         OR (M--H, random, 95% CI)   0.80 (0.63, 1.02)   0.08        73%             \<0.00001
   Northern China            2         1,817          OR (M--H, random, 95% CI)   0.57 (0.07, 4.64)   0.6         94%             \<0.0001
   Central China             8         10,791         OR (M--H, random, 95% CI)   0.84 (0.65, 1.08)   0.17        60%             0.01
   Southern China            5         4,898          OR (M--H, random, 95% CI)   0.76 (0.47, 1.24)   0.27        71%             0.008
   Inland areas              6         9,724          OR (M--H, random, 95% CI)   0.68 (0.44, 1.06)   0.09        83%             \<0.0001
   Coastal areas             9         7,782          OR (M--H, random, 95% CI)   0.87 (0.65, 1.17)   0.37        63%             0.006
  Homozygous genetic model                                                                                                        
   Overall                   15        10,714         OR (M--H, random, 95% CI)   0.74 (0.56, 0.98)   0.03        79%             \<0.00001
   Northern China            2         1,119          OR (M--H, random, 95% CI)   0.51 (0.05, 5.19)   0.57        95%             \<0.0001
   Central China             8         6,556          OR (M--H, random, 95% CI)   0.78 (0.58, 1.06)   0.12        72%             0.0009
   Southern China            5         3,039          OR (M--H, random, 95% CI)   0.70 (0.40, 1.22)   0.2         77%             0.002
   Inland areas              6         5,981          OR (M--H, random, 95% CI)   0.60 (0.36, 0.98)   0.04        87%             \<0.00001
   Coastal areas             9         4,733          OR (M--H, random, 95% CI)   0.84 (0.59, 1.18)   0.31        71%             0.0006
  Heterozygote comparison                                                                                                         
   Overall                   15        16,158         OR (M--H, random, 95% CI)   0.83 (0.74, 0.93)   0.001       64%             0.0003
   Northern China            2         1,660          OR (M--H, random, 95% CI)   0.77 (0.44, 1.36)   0.37        86%             0.008
   Central China             8         9,911          OR (M--H, random, 95% CI)   0.87 (0.75, 1.00)   0.06        62%             0.01
   Southern China            5         4,587          OR (M--H, random, 95% CI)   0.78 (0.63, 0.98)   0.03        66%             0.02
   Inland areas              6         8,958          OR (M--H, random, 95% CI)   0.77 (0.63, 0.94)   0.01        77%             0.0005
   Coastal areas             9         7,200          OR (M--H, random, 95% CI)   0.87 (0.75, 1.01)   0.06        53%             0.03

**Abbreviation:** M--H, Mantel--Haenszel.
